Condition
Psoriasis Palmaris
Total Trials
4
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Active Not Recruiting1
Recruiting1
Withdrawn1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT05938361Active Not RecruitingPrimary
Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis
NCT04950218Recruiting
Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
NCT04099979Withdrawn
A Pilot Study to Explore the Role of Gut Flora in Psoriasis
NCT05144165Unknown
Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines
Showing all 4 trials